Challenges of Precision Oncology
Since the Human Genome Project, the goal of interventional cancer research has been to isolate and develop treatments specifically for genetic causes of cancer. Today, there are several thousand clinical trials, and hundreds of FDA-approved therapies, that are dedicated to targeting and treating specific cancer types.
As the precision oncology industry continues to evolve, the amount of data and treatment options continues to increase exponentially. With this ever-growing amount of data, it is increasingly difficult for clinicians to keep up with the amount of research, data, and treatment options available.
Our precision oncology solutions are designed to streamline the data analysis and treatment matching process.
Need for Structured Data & Decision Support
Ever-Evolving Industry
People have a 50% chance of being diagnosed with cancer at some point in their lifetime, and this percentage continues to increase. As a result, precision medicine is an ever-evolving industry, with a focus to create treatments specific to current, new, and changing cancers.
Access Limitations
Oncologists need to have access to all available treatment options, whether it be a clinical trial, new FDA approved therapy, or even off-label therapies.
Streamlined Support
GenomOncology’s toolset helps clinicians keep up with this growing data, and pulls in all new information via an automated process, resulting in the most accurate, up-to-date information that can be easily consumed and utilized by users.
Our Precision Oncology Solution Set
GenomOncology’s toolsets are designed to streamline precision oncology processes. By keeping up with the information related to precision oncology, simply integrating with current systems and workflows, and presenting relevant data and analytics in a comprehensive manner, clinicians are able to reduce overhead and focus more on patient care.